Key facts
- This page summarizes Lisa Feng's Form 4 filing for ACM Research, Inc. (ACMR).
- 8 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 09 Mar 2026, 16:30.
Lisa Feng - 05 Mar 2026 Form 4 Insider Report for ACM Research, Inc. (ACMR)
- Reporting relationship
- Chief Financial Officer of ACM Research (Shanghai), Inc., a subsidiary of the Issuer
- Issuer ticker
- ACMR
- Reported as of
- 05 Mar 2026
- Net transaction value
- -$1,441,290
- SEC form
- 4
- Accepted by SEC
- 09 Mar 2026, 16:30:30 UTC
- Prior SEC filing
- 14 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark McKechnie, Attorney-in-Fact for Lisa Feng
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Lisa Feng filed Form 4 for ACM Research, Inc. (ACMR) on 09 Mar 2026.
Change
- Previous filing in this sequence was filed on 14 Nov 2025.
- Current net transaction value: -$1,441,290.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001779777
Primary reporting owner
Feng Lisa
- Relationship
- Chief Financial Officer of ACM Research (Shanghai), Inc., a subsidiary of the Issuer
- Address
- C/O ACM RESEARCH, INC., 42307 OSGOOD ROAD, SUITE I, FREMONT
- Signature
- /s/ Mark McKechnie, Attorney-in-Fact for Lisa Feng
- Signature date
- 09 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ACMR
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +15,000
- Change %
- +30%
- Price
- $4.55*
- Shares after
- 65,001
- Date
- 05 Mar 2026
- Ownership
- Direct
ACMR
transaction
Class A Common Stock
Sale
- Transaction value
- $400,970
- Shares
- -8,050
- Change %
- -12%
- Price
- $49.81
- Shares after
- 56,951
- Date
- 05 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F2
ACMR
transaction
Class A Common Stock
Sale
- Transaction value
- $349,168
- Shares
- -6,950
- Change %
- -12%
- Price
- $50.24
- Shares after
- 50,001
- Date
- 05 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F3
ACMR
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +15,000
- Change %
- +30%
- Price
- $4.55*
- Shares after
- 65,001
- Date
- 06 Mar 2026
- Ownership
- Direct
ACMR
transaction
Class A Common Stock
Sale
- Transaction value
- $681,836
- Shares
- -14,800
- Change %
- -23%
- Price
- $46.07
- Shares after
- 50,201
- Date
- 06 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F4
ACMR
transaction
Class A Common Stock
Sale
- Transaction value
- $9,316
- Shares
- -200
- Change %
- -0.4%
- Price
- $46.58
- Shares after
- 50,001
- Date
- 06 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ACMR
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- Shares
- -15,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 15,000
- Exercise price
- $4.55
- Footnotes
- F6
ACMR
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- Shares
- -15,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 06 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 15,000
- Exercise price
- $4.55
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 6 footnotes
Footnote F1
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.16 to $50.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4) and (5) to this Form 4.
Footnote F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.16 to $50.54, inclusive.
Footnote F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.51 to $46.48, inclusive.
Footnote F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.52 to $46.63, inclusive.
Footnote F6
The option is fully vested and exercisable.
SEC remarks
Chief Financial Officer of ACM Research (Shanghai), Inc., a subsidiary of the Issuer